|Day Low/High||33.74 / 34.71|
|52 Wk Low/High||24.75 / 79.90|
NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.
Radius Health anticipates an opinion from the CHMP regarding the MAA for Eladynos (abaloparatide-SC) before year-end
Mr. Hoiland brings unique experience in launching new products, creating growth strategies and leading high-performing organizations
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
Investors in Radius Health Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new August 18th contracts and identified one put and one call contract of particular interest.
Insiders at Bioverativ, Juno Therapeutics and three other companies have been buying up shares of their own stock recently.
Here's a technical look at how to play six stocks trending higher with unusual volume flows.
Investors in Radius Health Inc saw new options become available this week, for the January 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Radius Health is a takeover target.
Amgen's osteoporosis setback will likely be seen as providing a commercial boost to Radius Health, which secured U.S. approval in April for a competing osteoporosis drug, Tymlos.
Radius Health, Amgen and Paratek Pharmaceuticals were among the biotech movers in premarket trading on Monday.
Jim Cramer is bullish on Six Flags and Cara Therapeutics, but he's bearish on General Motors and Pandora.
Jim Cramer says he's amazed that stocks -- and gold, even -- are just yawning at Trump's move to fire FBI Director Comey.
Insiders at Twitter, Biogen and three other companies have been snapping up shares of their own stock lately.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.